|
MediciNova and University of Colorado Boulder Collaborate on Potential Novel …
MarketWatch (press release) Ibudilast has been used in asthma and post-stroke disorders in Japan for around 20 years. MediciNova has demonstrated utility of ibudilast in neurological disorders at higher doses with encouraging outcomes in company-sponsored clinical trials in … |
View full post on asthma – Google News